Ozsvari B - Search Results

1

Editorial: Metabolic reprogramming in breast cancer.

Scatena C, Naccarato AG, Ozsvari B, Scumaci D. Scatena C, et al. Among authors: ozsvari b. Front Oncol. 2022 Nov 10;12:1081171. doi: 10.3389/fonc.2022.1081171. eCollection 2022. Front Oncol. 2022. PMID: 36439453 Free PMC article. No abstract available.

2

Editorial: Reviews in cancer metabolism.

Jacobo-Herrera N, Ozsvari B. Jacobo-Herrera N, et al. Among authors: ozsvari b. Front Oncol. 2023 Mar 28;13:1167484. doi: 10.3389/fonc.2023.1167484. eCollection 2023. Front Oncol. 2023. PMID: 37056333 Free PMC article. No abstract available.

3

Novel Metabolic Approaches Targeting Cancer Cells.

Sebestyén A, Lisanti MP, Ozsvari B. Sebestyén A, et al. Among authors: ozsvari b. Cancers (Basel). 2023 Nov 16;15(22):5448. doi: 10.3390/cancers15225448. Cancers (Basel). 2023. PMID: 38001707 Free PMC article.

4

High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy.

Fiorillo M, Ózsvári B, Sotgia F, Lisanti MP. Fiorillo M, et al. Among authors: ozsvari b. Front Oncol. 2021 Oct 15;11:740720. doi: 10.3389/fonc.2021.740720. eCollection 2021. Front Oncol. 2021. PMID: 34722292 Free PMC article. Review.

5

A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity.

Ózsvári B, Magalhães LG, Latimer J, Kangasmetsa J, Sotgia F, Lisanti MP. Ózsvári B, et al. Front Oncol. 2020 Sep 15;10:1528. doi: 10.3389/fonc.2020.01528. eCollection 2020. Front Oncol. 2020. PMID: 33042796 Free PMC article.

6

First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.

Ózsvári B, Sotgia F, Lisanti MP. Ózsvári B, et al. Aging (Albany NY). 2020 May 24;12(11):10162-10179. doi: 10.18632/aging.103336. Epub 2020 May 24. Aging (Albany NY). 2020. PMID: 32452826 Free PMC article.

7

Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).

De Francesco EM, Ózsvári B, Sotgia F, Lisanti MP. De Francesco EM, et al. Among authors: ozsvari b. Front Oncol. 2019 Aug 7;9:615. doi: 10.3389/fonc.2019.00615. eCollection 2019. Front Oncol. 2019. PMID: 31440463 Free PMC article.

8

Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito-stemness and ribo-stemness features.

Peiris-Pagès M, Ozsvári B, Sotgia F, Lisanti MP. Peiris-Pagès M, et al. Among authors: ozsvari b. Aging (Albany NY). 2019 Jul 16;11(14):4801-4835. doi: 10.18632/aging.102054. Aging (Albany NY). 2019. PMID: 31311889 Free PMC article.

9

Azithromycin and Roxithromycin define a new family of "senolytic" drugs that target senescent human fibroblasts.

Ozsvari B, Nuttall JR, Sotgia F, Lisanti MP. Ozsvari B, et al. Aging (Albany NY). 2018 Nov 14;10(11):3294-3307. doi: 10.18632/aging.101633. Aging (Albany NY). 2018. PMID: 30428454 Free PMC article.

10

A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.

Sotgia F, Ozsvari B, Fiorillo M, De Francesco EM, Bonuccelli G, Lisanti MP. Sotgia F, et al. Among authors: ozsvari b. Cell Cycle. 2018;17(17):2091-2100. doi: 10.1080/15384101.2018.1515551. Epub 2018 Sep 26. Cell Cycle. 2018. PMID: 30257595 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page